Requip 2-Week Starter Kit
RxNorm 763160

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 763160 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Requip 2-Week Starter Kit.

The following semantic concepts and normalized strings are associated with this clinical entity:

SY
Requip 2-Week Starter Kit
AUI:2775644
View
BPCK
{2 (ropinirole 0.25 mg Oral Tablet [Requip]) / 5 (ropinirole 0.5 mg Oral Tablet [Requip]) / 7 (ropinirole 1 mg Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
AUI:2775643
View
TMSY
{2 (rOPINIRole 0.25 mg Oral Tablet [Requip]) / 5 (rOPINIRole 0.5 mg Oral Tablet [Requip]) / 7 (rOPINIRole 1 mg Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
AUI:3739335
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

SY

Synonym (SY):
Requip 2-Week Starter Kit
(Atom ID: 2775644)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Requip 2-Week Starter Kit
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
763160
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
2775644
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
SY
Synonym (Synonym of another TTY, given for clarity.)
Source Code
763160
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.
BPCK

Brand Name Pack (BPCK):
{2 (ropinirole 0.25 mg Oral Tablet [Requip]) / 5 (ropinirole 0.5 mg Oral Tablet [Requip]) / 7 (ropinirole 1 mg Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
(Atom ID: 2775643)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{2 (ropinirole 0.25 MG Oral Tablet [Requip]) / 5 (ropinirole 0.5 MG Oral Tablet [Requip]) / 7 (ropinirole 1 MG Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
763160
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
2775643
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
BPCK
Brand Name Pack ({# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name])
Source Code
763160
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.

Technical Attributes & Logic

RXN OBSOLETED
02/27/2013
Date the RxNorm atom became obsolete
TMSY

Tall Man Lettering Synonym (TMSY):
{2 (rOPINIRole 0.25 mg Oral Tablet [Requip]) / 5 (rOPINIRole 0.5 mg Oral Tablet [Requip]) / 7 (rOPINIRole 1 mg Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
(Atom ID: 3739335)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
{2 (rOPINIRole 0.25 MG Oral Tablet [Requip]) / 5 (rOPINIRole 0.5 MG Oral Tablet [Requip]) / 7 (rOPINIRole 1 MG Oral Tablet [Requip]) } Pack [Requip 2-Week Starter Kit]
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
O
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
763160
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
3739335
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
TMSY
Tall Man Lettering Synonym (Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs.)
Source Code
763160
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
RxNorm Vocabulary (RXNORM)
The official name and abbreviation for the vocabulary source.
Source Version
20AA_260601F
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
RxNorm Customer Service, , U.S. National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, (888) FIND-NLM, , https://support.nlm.nih.gov/support/create-case/, https://www.nlm.nih.gov/research/umls/rxnorm/
Source licensing contact information.